Skip to content

If one drug fully active, salvage HAART effective after treatment interruption

Lipid increase not needed for HIV protease inhibitors to trigger cardiovascular problems

Smallpox vaccination - US recommendations for HIV-positive people

Lack of knowledge about anti-HIV regimen predictor of poor adherence to HIV drugs

Indian company launches generic version of abacavir

Patient sues German university clinic after HIV test without consent

Thai AIDS death rate halved using sub-optimal therapy

40% increase in new heterosexual HIV diagnoses in UK in 2001

HAART does not prevent quicker rate of fibrosis in HIV/HCV coinfected patients, says study

Barebacking debate re-ignited; more sparks to come?

Basic measures to protect UK med students from HIV whilst working abroad

Closeted black men in US might play significant role in HIV transmission to partners

HIV antibodies revived as microbicide

Atazanavir and amprenavir both pitching for first line therapy with new resistance data

New antiretrovirals: `pipeline at its fullest for years`

New protease inhibitor TMC 114 effective for PI-exhausted patients in early study

T-1249 could salvage T-20 failure

Barebacking: not a simple phenemenon, US research shows